BRIEF-Oruka Therapeutics Announces Positive Week 28 Data For Orka-001 From The Ongoing Everlast-A Trial Showing Deepening Of Responses Without Additional Dosing

Reuters2026/09/23 11:05

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Oruka Therapeutics Inc ORKA.O:

ORUKA THERAPEUTICS ANNOUNCES POSITIVE WEEK 28 DATA FOR ORKA-001 FROM THE ONGOING EVERLAST-A TRIAL SHOWING DEEPENING OF RESPONSES WITHOUT ADDITIONAL DOSING
ORUKA THERAPEUTICS - ORKA-001 MAINTAINS FAVORABLE SAFETY AND TOLERABILITY PROFILE THROUGH WEEK 28
ORUKA THERAPEUTICS - TWO SERIOUS ADVERSE EVENTS REPORTED, NEITHER DEEMED DRUG RELATED
ORUKA THERAPEUTICS - 16-WEEK EVERLAST-B DATA EXPECTED IN FOURTH QUARTER 2026
ORUKA THERAPEUTICS - 52-WEEK EVERLAST-A DATA EXPECTED IN DECEMBER 2026

Source text: ID:nGNX10yvmc

Further company coverage: ORKA.O

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

BRIEF-Oruka Therapeutics Announces Positive Week 28 Data For Orka-001 From The Ongoing Everlast-A Trial Showing Deepening Of Responses Without Additional Dosing

You may also like

Crypto prices